Insider Trading History of Patel Snehal

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Patel Snehal since 2020. This trader's CIK number is 1806920. At the time of last reporting, Patel Snehal was the CEO and CFO of Greenwich Lifesciences, Inc.. (stock ticker symbol GLSI). Also see all insider trading activities at Greenwich Lifesciences, Inc..



Yearly summary of insider trading at Greenwich Lifesciences, Inc. (GLSI) by Patel Snehal

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 GLSI 30,500 $315,099 0 $0 0 $0
2024 GLSI 250,425 $3,475,081 0 $0 0 $0
2023 GLSI 52,100 $597,036 0 $0 0 $0
2022 GLSI 127,074 $1,364,409 0 $0 0 $0
2021 GLSI 1,840 $49,992 0 $0 0 $0
2020 GLSI 133,014 $745,009 0 $0 1,665,124 $0


Insider trading of Greenwich Lifesciences, Inc. (GLSI) by Patel Snehal

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-04-25 GLSI Buy 3,600 9.88 35,568
2025-04-25 GLSI Buy 3,600 9.88 35,568
2025-04-17 GLSI Buy 5,400 8.98 48,492
2025-04-07 GLSI Buy 3,600 9.10 32,760
2025-04-04 GLSI Buy 5,500 8.73 48,015
2025-01-10 GLSI Buy 2,500 12.51 31,275
2025-01-07 GLSI Buy 1,800 13.75 24,750
2025-01-06 GLSI Buy 1,100 13.31 14,641
2025-01-03 GLSI Buy 3,400 12.95 44,030
2024-09-26 GLSI Buy 1,500 14.63 21,945
2024-08-06 GLSI Buy 2,000 13.81 27,620
2024-08-05 GLSI Buy 5,500 13.18 72,490
2024-07-23 GLSI Buy 1,500 15.89 23,835
2024-06-13 GLSI Buy 174,825 14.30 2,499,997
2024-04-01 GLSI Buy 3,000 19.08 57,239
2024-03-22 GLSI Buy 2,500 19.98 49,950
2024-03-20 GLSI Buy 1,500 17.68 26,520
2024-03-05 GLSI Buy 30,500 12.49 380,945
2024-03-04 GLSI Buy 4,100 13.03 53,423
2024-02-16 GLSI Buy 10,800 11.16 120,528
2024-02-15 GLSI Buy 12,700 11.07 140,589
2023-11-10 GLSI Buy 5,000 10.17 50,839
2023-11-03 GLSI Buy 3,500 9.11 31,884
2023-10-26 GLSI Buy 2,500 7.97 19,925
2023-10-25 GLSI Buy 2,500 7.91 19,775
2023-10-10 GLSI Buy 1,000 9.07 9,070
2023-10-04 GLSI Buy 2,000 8.63 17,260
2023-09-19 GLSI Buy 4,000 8.95 35,800
2023-09-11 GLSI Buy 1,000 9.48 9,480
2023-08-22 GLSI Buy 1,000 9.97 9,970
2023-08-04 GLSI Buy 2,000 10.55 21,100
2023-07-21 GLSI Buy 1,000 9.20 9,200
2023-05-17 GLSI Buy 1,000 11.69 11,690
2023-04-19 GLSI Buy 7,000 11.10 77,700
2023-04-18 GLSI Buy 2,000 11.12 22,240
2023-04-11 GLSI Buy 5,000 12.42 62,100
2023-03-10 GLSI Buy 1,000 12.12 12,120
2023-02-17 GLSI Buy 600 16.53 9,918
2023-02-10 GLSI Buy 1,000 18.68 18,680
2023-01-27 GLSI Buy 2,000 19.35 38,700
2023-01-20 GLSI Buy 1,500 17.37 26,055
2023-01-06 GLSI Buy 1,500 15.18 22,770
2022-12-29 GLSI Buy 4,000 15.19 60,760
2022-12-16 GLSI Buy 1,000 13.01 13,010
2022-12-09 GLSI Buy 2,000 13.11 26,220
2022-12-02 GLSI Buy 1,000 13.84 13,840
2022-11-02 GLSI Buy 2,000 8.79 17,580
2022-10-14 GLSI Buy 3,000 9.75 29,250
2022-10-07 GLSI Buy 2,000 9.72 19,440
2022-09-30 GLSI Buy 1,000 9.46 9,460
2022-09-30 GLSI Buy 1,000 9.46 9,460
2022-09-29 GLSI Buy 1,000 9.23 9,230
2022-06-24 GLSI Buy 29,000 9.13 264,770
2022-06-16 GLSI Buy 8,000 7.13 57,040
2022-06-14 GLSI Buy 12,000 7.91 94,920
2022-06-10 GLSI Buy 12,000 8.33 99,960
2022-06-09 GLSI Buy 4,500 10.90 49,050
2022-06-07 GLSI Buy 6,000 8.55 51,300
2022-06-03 GLSI Buy 9,250 8.35 77,237
2022-06-02 GLSI Buy 6,774 7.38 49,992
2022-04-21 GLSI Buy 6,000 16.09 96,540
2022-04-19 GLSI Buy 6,000 16.74 100,439
2022-02-11 GLSI Buy 5,500 19.80 108,900
2022-02-04 GLSI Buy 5,000 19.59 97,950
2022-01-13 GLSI Buy 1,000 19.99 19,990
2022-01-03 GLSI Buy 2,050 23.82 48,831
2021-12-14 GLSI Buy 1,840 27.17 49,992
2020-11-19 GLSI Buy 2,000 5.40 10,796
2020-09-29 GLSI Buy 16,667 4.60 76,718
2020-09-29 GLSI Option Ex 1,665,124 .00 0
2020-09-29 GLSI Buy 114,347 5.75 657,495

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Patel Snehal (CEO and CFO of Greenwich Lifesciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.